Quinoxaline

Quinoxaline

SCHEMBL1259050

CCOCC.c1ccc2nccnc2c1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 4/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 1/20 0.41
NCF1 P14598 1/20 0.40
TLR8 Q9NR97 1/20 0.39
AHR P35869 1/20 0.39
MPO P05164 2/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
ELANE P08246 1/20 0.37
TSHR P16473 1/20 0.36
POLB P06746 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ATM Q13315 1/20 0.36
GAA P10253 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL1257445 0.83 ALDH1A1 (0.68) ALDH1A1KDM4EMAPTNPC1NCF1
Phenazine SCHEMBL2291612 0.80 MAPT (0.58) ALDH1A1KDM4EMAPTNPC1NCF1
Quinoxaline SCHEMBL19877227 0.80 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTNPC1NCF1
Quinoxaline SCHEMBL5315 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTNCF1MEN1
Quinoxaline SCHEMBL6928518 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTNCF1MEN1
Quinoxaline SCHEMBL29355228 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTNCF1MEN1
Quinoxaline SCHEMBL30320908 0.79 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTNCF1MEN1
Ether SCHEMBL2007543 0.78 LOXL2 (0.46) ALDH1A1KDM4EMAPTNPC1NCF1
Quinoxaline SCHEMBL27924506 0.76 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTNPC1NCF1
Quinoxaline SCHEMBL27596038 0.76 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTNPC1NCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130224624-A1 PROTON EXCHANGE MEMBRANES RENO (US) 2013-08-29 US claimed
US-8071710-B2 Thermoplastic polyphenoxyquinoxaline and method of preparing the same THE UNIVERSITY OF AKRON (US) 2011-12-06 US claimed
US-20110033776-A1 PROTON EXCHANGE MEMBRANES Board of regents of the Nevada System of Higher Education, on Behalf of the University of 2011-02-10 US claimed
US-20100048857-A1 THERMOPLASTIC POLYPHENOXYQUINOXALINE AND METHOD OF PREPARING THE SAME THE UNIVERSITY OF AKRON (US) 2010-02-25 US claimed
US-20040102584-A1 Low dielectric constant materials with polymeric networks LAU KREISLER S (US) 2004-05-27 US claimed
US-6713590-B2 FABRICATED FROM FIRST COMPONENT COMPRISING POLYMERIC STRAND AND SECOND COMPONENT COMPRISING MOLECULE HAVING CENTRAL PORTION WITH AT LEAST THREE ARMS EXTENDING THEREFROM HONEYWELL INTERNATIONAL INC. 2004-03-30 US claimed
EP-1303550-A4 LOW DIELECTRIC CONSTANT MATERIALS WITH POLYMERIC NETWORKS HONEYWELL INT INC (US) 2003-07-30 EP claimed
EP-1303550-A1 LOW DIELECTRIC CONSTANT MATERIALS WITH POLYMERIC NETWORKS Honeywell International, Inc. (US) 2003-04-23 EP claimed
US-6423811-B1 ACETYLENIC COPOLYMERS; INTERPENETRATING POLYMER NETWORK HONEYWELL INTERNATIONAL INC. 2002-07-23 US claimed
US-20020037941-A1 Low dielectric constant materials with polymeric networks LAU KREISLER S (US) 2002-03-28 US claimed
WO-2002006366-A1 LOW DIELECTRIC CONSTANT MATERIALS WITH POLYMERIC NETWORKS HONEYWELL INTERNATIONAL INC. (US) 2002-01-24 WO claimed
EP-3071582-B1 MITOCHONDRIA-TARGETED DICARBONYL SEQUESTERING COMPOUNDS RES & INNOVATION UK (GB) 2020-04-29 EP disclosed
EP-3623375-A1 MITOCHONDRIA-TARGETED DICARBONYL SEQUESTERING COMPOUNDS United Kingdom Research and Innovation (GB) 2020-03-18 EP disclosed
CN-105873936-B Mitochondrially targeted dicarbonyl chelate compounds 医药研究委员会 2018-09-14 CN disclosed
US-9963474-B2 Mitochondria-targeted dicarbonyl sequestering compounds MEDICAL RESEARCH COUNCIL (GB) 2018-05-08 US disclosed
US-20020037941-A1 Low dielectric constant materials with polymeric networks LAU KREISLER S (US) 2002-03-28 US disclosed
WO-2002006366-A1 LOW DIELECTRIC CONSTANT MATERIALS WITH POLYMERIC NETWORKS HONEYWELL INTERNATIONAL INC. (US) 2002-01-24 WO disclosed
US-3956238-A Polyetherquinoxalines GENERAL ELECTRIC COMPANY (US) 1976-05-11 US disclosed
US-3956238-A Polyetherquinoxalines GENERAL ELECTRIC COMPANY (US) 1976-05-11 US disclosed
US-3852244-A POLYETHERQUINOXALINES GEN ELECTRIC 1974-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048857-A1 THERMOPLASTIC POLYPHENOXYQUINOXALINE AND METHOD OF PREPARING THE SAME RECQL, BLM, RB1 ALDH1A1 3956/4885KDM4E 408/4885MAPT 4041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.